An observational study in Primary Hyperparathyroidism, sponsored by University of Nebraska. Completed at 6 sites in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2024-09-26.
Sponsored by University of Nebraska · Observational
The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.
This will be a multi-institutional prospective study in which patients that have undergone parathyroidectomy with intra-operative PTH assessment. The success of minimally invasive parathyroidectomy without and with intra-operative PTH will be assessed for each patient. Success for exploration without intra-operative PTH will be defined as directed exploration with detection of an abnormal parathyroid in the location suggested by imaging. Success with intra-operative PTH will be defined as per standard protocols (50% or > decrease in intra-operative PTH following excision).
105 studies on the registry are indexed under Hyperparathyroidism, Primary; 23 are open to participants now.
This study's enrollment of 175 is above the median of 145 across 42 observational studies indexed under Hyperparathyroidism, Primary.
Browse Hyperparathyroidism, Primary studies →University of Nebraska is the lead sponsor of 495 studies on the registry; 68 are open to participants now.
Of its 83 completed or terminated interventional studies of FDA-regulated products, 52 (63%) have results posted.
Counted across the registry records on this site, refreshed daily.
Otolaryngology, Head and Neck Surgery clinic patients
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-No history of primary hyperparathyroidism
Ran from Jun 2010 to primary completion in Dec 2014, 53 months.
Of 18 observational studies under Hyperparathyroidism, Primary, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 69. This study's 53 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hyperparathyroidism, Primary →